Table 1.
Studies included in the systematic review (32 studies)
| Study (year) | N (% male) * | Mean age ± SD/age range | Health conditions | # of sample collections across 24 hours | Components of CBC included |
|---|---|---|---|---|---|
| Abo et al. (1978) [21] | 6 | 23–45 | Healthy | 7 | Lymphocytes |
| Ackermann et al. (2012) [22] | 15 (100%) | 23.7 ± 5.4/19–35 | Healthy | 16 | Leukocytes, lymphocytes, monocytes |
| Akbane (1969) [23] | 9 (55.5%) | 9–43 | Healthy | 8 | Eosinophils |
| Akbulut et al. (2003) [24] | 10 (0%) | 34A/20–48 | Healthy | 6 | Leukocytes, neutrophils |
| Aoto et al. (2014) [25] | 10 (100%) | 30 ± 2.6/26–34 | Healthy | 4 | Erythrocytes, leukocytes, platelets |
| Baldwa et al. (1977) [26] | 10 | 16–25 | Healthy | 4 | Basophils |
| Bates et al. (1994) [27] | 18 (60%) | 19–25 | Asthma | 4 | Eosinophils |
| Dahl (1977) [28] | 8 | 24–58 | Healthy | 8 | Eosinophils |
| Dahl et al. (1978) [29] | 9 | 21–66 | Healthy | 7 | Eosinophils |
| Fournier et al. (2018) [30] | 25 (56%) | 24.3 ± 2.6/≥18 | Healthy | 6 | Platelets |
| Grattan et al. (2003) [31] | 10 (40%) | 39A/24–63 | Healthy | 4 | Basophils |
| Gresele et al. (1993) [32] | 10 (40%) | 22–34 | Healthy | 3 | Platelets |
| Haus et al. (1990) [33] | 10 (50%) | 31 ± 11/21–50 | Healthy | 6 | Eosinophils, lymphocytes, neutrophils |
| Jennings et al. (1990) [34] | 12 (100%) | 27.6/23–35 | Healthy | 7 | Eosinophils, lymphocytes, neutrophils |
| Kanabrocki et al. (1991) [35] | 2 (50%) | 47 | Healthy | 11 | Basophils, eosinophils, erythrocytes, leukocytes, lymphocytes, monocytes neutrophils, platelets |
| Kanabrocki et al. (1999) [36] | 11 (100%) | 55.2 ± 9.7/46–72 | Healthy | 8 | Platelets |
| Kanabrocki et al. (1990) [37] | 9 (100%) | 44.3 ± 1.9/41–47 | Healthy | 8 | Basophils, eosinophils, erythrocytes, hematocrit, hemoglobin, leukocytes, lymphocytes, monocytes, neutrophils, platelets |
| Krzyzanski et al. (2021) [38] | 24 (0%) | 22–37 | Healthy | 10 | Basophils, neutrophils |
| Lasselin et al. (2015) [39] | 9 (100%) | 22–27 | Healthy | 14 | Eosinophils, leukocytes, lymphocytes, monocytes, neutrophils |
| Manfredini et al. (1994) [40] | 10 (50%) | 65/24–84 | Healthy | 4 | Basophils, eosinophils, erythrocytes, hemoglobin, leukocytes, lymphocytes, monocytes, neutrophils, platelets |
| Melchart et al. (1992) [41] | 13 (100%) | 23.7 ± 2.9B/21–32 | Healthy | 6 | Eosinophils, erythrocytes, hematocrit, hemoglobin, leukocytes, lymphocytes, monocytes, neutrophils, platelets |
| Pavlishchuk et al. (1979) [42] | 10 | Healthy | 6 | Basophils, platelets | |
| Postma et al. (1985) [43] | 16 (100%) | 53 ± 4.7/43–60 | Chronic, partially reversible airflow obstruction | 7 | Leukocytes, lymphocytes |
| Reinberg et al. (1977) [44] | 9 (66.7%) | 23.8 ± 4.9/19–28 | Healthy | 6 | Leukocytes |
| Rosenfeld et al. (1994) [45] | 12 (100%) | 18–22 | Healthy | 4 | Hematocrit, leukocytes, platelets |
| Spector et al. (2012) [46] | 12 | Asthma | 15 | Eosinophils | |
| Swoyer et al. (1989) [2] | 150 (52.7%) | 24 ± 10/14–34 | Healthy | 6 | Basophils, eosinophils, erythrocytes, hematocrit, hemoglobin, leukocytes, lymphocytes, monocytes, neutrophils, platelets |
| Tornatore et al. (1998) [47] | 5 (100%) | 31 ± 5.8/24–37 | Healthy | 6 | Lymphocytes |
| Touitou et al. (1986) [48] | 7 (100%) | 24 ± 3.9/19–31 | Healthy | 6 | Erythrocytes, hematocrit, hemoglobin |
| Wempe et al. (1992) [49] | 9 (67%) | 24 ± 6.8/18–39 | Episodic wheezing consistent with asthma | 6 | Eosinophils |
| Winkel et al. (1981) [50] | 21 (47.6%) | 37.4 ± 11.4/24–55 | Healthy | 6 | Basophils, eosinophils, leukocytes, lymphocytes, neutrophils, monocytes |
| Zaslavskaia et. al (1974) [51] | 50 | 23–72 | Healthy | 5 | Platelets |
AMedian,
BSEM,
*if sex of participants not mentioned, then left blank in table.